1
HEALTH ECONOMICS & MARKET ACCESS RESOURCE LIST
Workshop by HealthEconomics.Com and Global Outcomes Group; for more
information, visit: http://www.healtheconomics.com/heor-writing-workshop/
Faculty-recommended Health Economics & Market Access Medical Writing Resource List (in no
particular order):
HealthEconomics.Com website at http://www.healtheconomics.com contains thousands of resources on
health economics, HTA, market access, and more.
4 Drivers for Successful Literature Reviews, UBC - November 05, 2014, found at:
http://www.ubc.com/blog/4-drivers-successful-literature-reviews
Bakst A, et al. Panel 7: Communication and reporting health economic information. Value in Health.
1999;2(2):103-106.
Being mortal : medicine and what matters in the end. By Gawande Atul. New York; Metropolitan Books:
Henry Holt & Company, 2014.
Berger ML, Ed. International Society for Pharmacoeconomics and Outcomes Research). Health Care
Cost, Quality, and Outcomes: ISPOR book of terms. Available at:
http://ispor.org/publications/BooksIndex.asp. Or search on Amazon for a used copy.
Blog by Bonny McClain, geared towards medical writers and providing details of specific tools used:
www.dataanddonuts.org
Bonk RJ. Conversance with fundamentals of health economics [AMWA Pocket Training]. AMWA website.
www.amwa.org/pocket_trainings.
Briggs A, Sculpher M. An introduction to Markov modeling for economic evaluation.
Pharmacoeconomics. 1998;13(4):397-409.
Chawla M. Towards a common goal: Health economics and medical writing. Powerpoint Presentation.
Kinapse Ltd. 2013;Oct. Available from: http://www.healtheconomics.com/resource/towards-acommon-goal-health-economics-and-medical-writing/
2
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration:
A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task
Force. Found at: Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation
reporting standards (CHEERS)—Explanation and elaboration: A report of the ISPOR health economic
evaluations publication guidelines good reporting practices task force. Value Health 2013;16:231-50.
Dant, Christopher. Writing The Biomedical Manuscript: A Systematic Approach. Powerpoint
Presentation. Stanford Medical School. Manuscript Writing. Part I. Available from:
http://medblog.stanford.edu/lane-faq/archives/Ms.Writing_I.ppt
Detsky AS, Nagler IG. A clinician’s guide to cost-effectiveness. Am Coll Physicians. 1990;113:147-154.
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the
BMJ. BMJ. 1996;313:275-283.
Enhancing Communications for Health Outcomes (ECHO) Laboratory, multimedia communications
laboratory ideal for message testing and for formative research at Dana-Farber / Harvard Cancer Center.
More information:
http://www.dfhcc.harvard.edu/index.php?id=1318&no_cache=1&tx_ttnews%5Btt_news%5D=780
Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network website http://www.equator-network.org/
Fairclough J et al. Incorporation of the Academy of Managed Care Pharmacy (AMCP) eDossier System to
Enhance the Dossier Request Process, Poster Presentation, Drug Information Association (DIA) Medical
Communications Workshop 2011: Navigating the Waves of Medical Communications, Carlsbad, CA
(March 7-10, 2011).
Fanshawe J. Health economics: too important to be left to health economists. Mediaxial. Available
from: http://www.medaxial.com/articles/health_economics-too_%20important.pdf
Gold MR et al, Eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
Graf C et al for the International Society for Medical Publication Professionals Good publication practice
for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330
doi: 10.1136/bmj.b4330
Hazard EH, et al. Can they hear us now (This second article on health economics will present several
methods for effectively communicating the value of medicines to nonscientific audiences). Product
Management Today. 2007;18(12), December.
HTA Roadmap: http://www.ispor.org/HTARoadMaps/Default.asp
International Committee of Medical Journal Editors (ICMJE) recommendations for the conduct,
reporting, editing, and publication of scholarly work in medical journals: updated December 2014.
Available from: http://www.icmje.org/icmje-recommendations.pdf
3
ISPOR Good practices for outcomes research and use in health care decisions - HEALTH ECONOMIC
EVALUATION PUBLICATION GUIDELINES – CHEERS: GOOD REPORTING PRACTICES http://www.ispor.org/TaskForces/EconomicPubGuidelines.asp
Malone DC, Sullivan SD, Veenstra DL. Determining cost values for health care resources in
pharmacoeconomic studies. Formulary. 2011;36(4):294-299.
Mealing S. Medical writing and health economics/market access: a health economist’s view. Guest
Editorial. Medical Writing. 2013; 22(3):192-193.
Medical illuminations : using evidence, visualization, and statistical thinking to improve healthcare. By
Howard Wainer. Publisher: Oxford ; New York, NY : Oxford University Press, 2014.
Medina RD, Khetia D, Topiwala PJ, Willey VJ, Sloskey GE, Langhoff W. “Evaluating the Value of Clinical
and Economic Evidence-Based Information from Dossier Submissions Using the Academy of Managed
Care Pharmacy (AMCP) Format”, Poster Presentation, Drug Information Association (DIA) Medical
Communications Workshop 2011: Navigating the Waves of Medical Communications, Carlsbad, CA
(March 7-10, 2011).
Moher D, Schulz KF, Simera I, Altman DG. Guidance for Developers of Health Research Reporting
Guidelines. PLoS Medicine. 2010 Feb 16;7(2):e1000217.
Moore-Totten J, Tam I. Strategies for Complying with Version 3.0 of the AMCP Dossier Format, Poster
Presentation, Drug Information Association (DIA) Medical Communications Workshop 2011: Navigating
the Waves of Medical Communications, Carlsbad, CA (March 7-10, 2011).
Motheral B et al. A checklist for retrospective database studies—report of the ISPOR Task Force on
Retrospective Databases. Value Health. 2003;3(2):90-97.
Neumann PJ, Bliss SK. FDA Actions Against Health Economic Promotions, 2002–2011. Value in Health.
2012;15(6):948 – 953.
Neumann PJ, Rosen AB, Weinstein MC. Medicare and cost-effectiveness analysis. N Engl J Med.
2005;353(14):1516-1522.
Peeples P, Drake T. “SPLAT! How HEOR Communication Tools Fall Flat With Your Customers – But Don’t
Have To!”, tHEORetically Speaking blog, February 13, 2015.
Peterson AM, et al. A checklist for medication compliance and persistence using retrospective
databases. Value Health. 2007;10(1):3-12
PRISMA - Preferred Reporting Items for Systematic Reviews and Meta-Analyses, an evidence-based
minimum set of items for reporting in systematic reviews and meta-analyses, found at
http://www.prisma-statement.org/. This includes following the Preferred Reporting items for
Systematic Reviews and Meta-Analyses (PRISMA) statement. The PRISMA statement outlines an industry
standard for systematic reviews. The PRISMA Statement consists of a 27item checklist (http://www.prisma-statement.org/statement.htm ) and a four-phase flow diagram
4
(http://www.prisma-statement.org/2.1.4%20-%20PRISMA%20Flow%202009%20Diagram.pdf). It is an
evolving document that is subject to change periodically as new evidence emerges. In fact, the PRISMA
Statement is an update and expansion of the now-out dated QUOROM Statement. This website contains
the current definitive version of the PRISMA Statement. The PRISMA Explanation and Elaboration
document (http://www.prisma-statement.org/usage.htm) explains and illustrates the principles
underlying the PRISMA Statement. It is strongly recommended that it be used in conjunction with the
PRISMA Statement.
Rascati KL. Essentials of Pharmacoeconomics , Second Edition. Philadelphia: Lippincott, Williams, &
Wilkins, 2014.
Rothermel C, Peeples P. “Getting Published. The Last Stage of the Research Process”. Podcast,
HealthEconomics.Com CONNECTED COMMUNITY™ Podcast Series,
2014. http://www.healtheconomics.com/home/connected-community-podcasts/connectedcommunity-podcast-caitlin-rothermel-of-medlitera/
Rothermel C. What is health economics and outcomes research? A primer for medical writers. AMWA
Journal. 2013;28(3):98-103.
Rothermel C. “Model Naked: Some Thoughts on Transparency in Health Economics Writing”,
tHEORetically Speaking blog, February 18, 2014, http://healtheconblog.com/2014/02/18/model-nakedsome-thoughts-on-transparency-in-health-economics-writing
Symonds T, Hackford C, Abraham L. A review of FDA warning letters and notices of violation issued for
patient-reported outcomes promotional claims between 2006 and 2012. Value Health. 2014
Jun;17(4):433-7.
Stewart KA, Neumann PJ. FDA Actions against Misleading or Unsubstantiated Economic and Quality-ofLife Promotional Claims:An Analysis of Warning Letters and Notices of Violation. Value in Health.
2002;5(5):390-397.
The visual display of quantitative information. By Edward R Tufte. Publisher: Cheshire, Conn. (Box 430,
Cheshire 06410) : Graphics Press, ©1983.
Thinking, fast and slow. By Daniel Kahneman. Publisher: New York : Farrar, Straus and Giroux, 2011.
Whittington R. Health economists and medical writers: collaboration or collision? Medical Writing.
2013;22(3):174-177.
Yang BM. Guidance for writing excellent research manuscripts for submission to Value in Health
Regional Issues. Part 1. ISPOR News Across Asia Volume 3 No. 4 Winter 2014, ISPOR Asia Consortium
Newsletter. Available at: http://www.ispor.org/consortiums/asia/Guidance-for-Writing-ExcellentResearch-Manuscripts-for-VIHRI.pdf
HTA Organizations
5











International Network of Agencies for Health Technology Assessment (INAHTA) –
http://www.inahta.org/
European Network for Health Technology Assessment (EUNetHTA) – http://www.eunethta.eu/
Agency for Healthcare Research & Quality (AHRQ) Technology Assessment Program –
http://www.ahrq.gov/research/findings/ta/index.html
Agence des technologies et des modes intervention en sante (AETMIS) –
http://www.informa.msss.gouv.qc.ca/Details.aspx?Id=B8wIqr0vga8=
Australian Government HTA – http://www.health.gov.au/hta
Blue Cross Blue Shield (BCBS) Technology Evaluation Center –
http://www.bcbs.com/blueresources/tec/
Canadian Agency for Drugs and Technologies in Health (CADTH) – http://www.cadth.ca/en
German Agency for Health Technology Assessment (DAHTA) –
http://www.dimdi.de/static/en/hta/dahta/
National Institute for Health and Care Excellence (NICE; UK based) – https://www.nice.org.uk/
National Institute for Health Research (NIHR; UK based) –
http://www.nets.nihr.ac.uk/programmes/hta
Washington Health Care Authority (HCA) Health Technology Assessment Program –
http://www.hca.wa.gov/hta/Pages/index.aspx
HTA Databases
 Centre for Reviews and Dissemination – (http://www.york.ac.uk/inst/crd/)
 The Cochrane Library: Technology Assessment Database –
(http://onlinelibrary.wiley.com/o/cochrane/cochrane_clhta_articles_fs.html)
 TRIP Database – (http://www.tripdatabase.com/)
Systematic Review Resources
 The Cochrane Collaboration – http://www.cochrane.org/
 CRD/University of York guidance – http://www.york.ac.uk/inst/crd/pdf/Systematic_Reviews.pdf
 PROSPERO database of systematic reviews – http://www.crd.york.ac.uk/PROSPERO/
 Scottish Intercollegiate Guidelines Network (SIGN) search filters for different study types:
http://www.sign.ac.uk/methodology/filters.html
 SIGN critical appraisal checklists – http://www.sign.ac.uk/methodology/checklists.html
 Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working
Group – http://www.gradeworkinggroup.org/index.htm
Centers for Medicare & Medicaid Services (CMS)—cms.gov








Statistics
Medicare, Medicaid, CHIP essentials and health plans
National Health Expenditure Data, http://www.cms.gov/Research-Statistics-Data-andSystems/Statistics-Trends-and-Reports/NationalHealthExpendData/index.html
CMS Innovation Center, http://innovation.cms.gov
Fee schedules for physicians, hospitals, etc
Prescription drug coverage
Demonstration projects
Electronic health records and e-prescribing
6

Medicare & You yearly report for patients (http://www.medicare.gov/medicare-andyou/medicare-and-you.html)
Kaiser Family Foundation—www.kff.org







Medicaid and Medicare Fact Sheets and Primers
Market Trackers
Health Insurance Exchanges
Children’s Health Insurance Program (CHIP)
Affordable Care Act
Issues for 2015
Health policy insights
Others






















AAPC (ICD-10, coding)— https://www.aapc.com
American Medical Association (coding, solutions for practice)—http://www.ama-assn.org
Accenture (insights)— http://www.accenture.com/us-en/industry/health/Pages/health-index.aspx
Agency for Healthcare Research and Quality—http://www.ahrq.gov
ASHP Guidelines on P&T—
http://www.ashp.org/doclibrary/bestpractices/formgdlptcommformsyst.pdf
Association for Corporate Health Risk Management (payer-side insights)— https://www.achrm.org
Association of Health Care Journalists (resources, blogs, webinars)—
http://www.healthjournalism.org
Avalere Health (insights)—http://avalere.com
Campbell Alliance (insights)—http://www.campbellalliance.com
Center for Value-Based Insurance Design (U of MI)—http://vbidcenter.org
Commonwealth Fund—www.commonwealthyfund.org
Congressional Budget Office—cbo.gov
CPM HealthGrades (hospital info, quality, performance)—http://www.cpmhealthgrades.com
Deloitte (insights, Center for Health Solutions)—http://www2.deloitte.com/us/en/industries/lifesciences-and-health-care.html?icid=top_life-sciences-and-health-care
Dept of Health & Human Services (ASPE Issue Briefs)—http://aspe.hhs.gov
EMD Serono (drug marketplace digests)—www.emdserono.com/
Express Scripts—The Lab, http://lab.express-scripts.com
Express Scripts/Medco—The Drug Trend Report, http://lab.express-scripts.com/drug-trendreport/introduction/year-in-review
o Health care issues
Health Industries Research Companies (managed oncology, specialty pharma, quality)—
http://www.hirc.com
Institute of Medicine (quality, issues)—http://www.iom.edu
IRS (tax payer provisions)— http://www.irs.gov/Affordable-Care-Act/Affordable-Care-Act-TaxProvisions
Joint Commission (safety, quality, hospital accreditation)— http://www.jointcommission.org
Joint Commission on Health Care (costs)—
7

McKesson (reimbursement, specialty pharma, cost trends)—http://www.mckesson.com

National Association of Community Health Centers (research, policy issues)—
http://www.nachc.com/issues.cfm
National Business Coalition on Health (employer fees/penalties)—http://www.nbch.org
National Conference of State Legislatures (state-specific information on health)—
http://www.ncsl.org/research/health.aspx
National Pharmaceutical Council (research library, issues)—
http://www.nationalpharmaceuticalcouncil.org
Price Waterhouse Coopers (insights)—www.pwc.com
q1Medicare.com—Part D and MA plan cost information—http://www.q1medicare.com
The Leapfrog Group (employer-based coalition on quality, safety, transparency)—
http://www.leapfroggroup.org
The RPM Report (insight on regulation, FDA, CMS)—
https://www.pharmamedtechbi.com/publications/rpm-report
United Healthcare (provider, employer info)—http://www.uhc.com/united-for-reform
Verisk Health (infographics, resources, blog)— www.answers.veriskhealth.com/ideas









Reporting Standards
1. Observational Studies
STROBE – Strengthening the Reporting of Observational Studies in Epidemiology
2. Systematic Reviews and Meta-analyses
PRISMA – Preferred Reporting items for Systematic Reviews and Meta-Analyses
MOOSE – Meta-analysis of observational studies in epidemiology: a proposal for
reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
3. Economic Evaluations
CHEERS – Consolidated Health Economic Evaluation Reporting Standards Statement
Randomized Controlled Trials
CONSORT – Consolidated Standards of Reporting Trials
QUOROM – Quality of Reporting of Meta-Analyses checklist
4. Comparative Effectiveness Research
GRACE – Good ReseArch for Comparative Effectiveness
Research Standards
8
5. ISPOR.org > Research Tools > Good Practices for Outcomes Research Index
a. Example: Good Research Practices for Comparative Effectiveness Research: Defining,
Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data
Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force
Report—Part I
6. APA Style Guide
a. Summary available: https://owl.english.purdue.edu/owl/resource/560/19/
Disclaimer: This list is not exhaustive. Helpful Hint: Google is your friend.
Journals and other Publications (for complete list and hyperlinks, visit HealthEconomics.Com
(http://www.healtheconomics.com/category/journals)
AHA News
American Journal Of Bioethics
American Journal of Health Economics
American Journal Of Managed Care
American Journal Of Medicine (“The Green Journal”)
American Journal Of Public Health
Annals Of Internal Medicine
Annals Of Pharmacotherapy
Applied Health Economics And Health Policy
Bandolier: Evidence-Based Journal
BMC Health Services Research
Cancer News On The Net
CDC Morbidity And Mortality Weekly
Clinical Therapeutics
Cost Effectiveness And Resource Allocation
Current Medical Research Opinion
Disease Management And Clinical Outcomes
Economics And Human Biology
9
European Journal Of Health Economics
Expert Review OfPharmacoeconomics And Outcomes Research
Formulary
Frontiers In Pharmacoeconomics And Health Outcomes
Health And Quality Of Life Outcomes
Health Economics Knowledge At Wharton
Health Economics Review
Health Facilities Management Magazine
Health Informatics Journal
Health Services Research
Healthcare Innovation And Integrated Care Journal
Healthcare Reimbursement Monitor
International Journal Of Health Care Finance And Economics
International Journal Of Health Policy And Management
International Journal Of Technology Assessment In Health Care
ISPOR Connections
Journal Of American Medical Association
Journal Of Biomedical Informatics
Journal Of Clinical Epidemiology
Journal Of Development Effectiveness
Journal Of Drug Assessment
Journal Of Evaluation In Clinical Practice
Journal Of Health Economics
Journal Of Healthcare Finance
Journal of Managed Care & Specialty Pharmacy
Journal of Managed Care Medicine
Journal Of Medical Economics
Journal Of Mental Health Policy And Economics
Journal Of Occupational And Environmental Medicine
Journal Of Pharmaceutical Health Services Research
Journal Of Pharmacy Technology
10
Journal Of Postgraduate Medicine
Journal Of Risk Analysis
Journal Or Euromed Pharmacy
Journals In Medical Informatics
Knowledge At Wharton Health Economics
LDI Health Economist
Managed Care Magazine
Managed Care Weekly Watch Weekly Newsletter
Managed Healthcare Executive
Medical Decision-Making
Medical Letter On Drugs And Therapeutics
New England Journal Of Medicine
Online Journal Of Nursing Informatics
Pharmacoeconomics
Pharmacy Times
Pharmacy Week Journal
Preventing Chronic Disease
Public Health Reports Online
Quality Of Life Research
Risk Analysis Journal
Specialty Pharmacy Times
Statistics In Medicine
Statistics In Medicine
Studies In Health Technology And Information
The Journal Of The Economics Of Ageing
11
Ensuring message communication in Market access Value dossiers
Karin Hawkinson Scientific Director, Payer Communications, Evidera
Key considerations to make sure your dossier is on track
Remember your goal
Remember your audience
Market access value dossiers are designed to
communicate the full picture of a product’s value—
using a compelling value story—supported by the
best available evidence to economically sensitive
customers
Your audience may be:

Internal pharma company affiliates

External payers, decision makers, or clinical
advisors
Ensure your message is incorporated
Select and translate the information

Present the relevant information

Ways to ensure translation

Focus on the value story


Get back to basics: ask yourself what is
relevant
Identify what distinguishes the product


List the key points and rework from there
Consider what is needed for each audience


Cut the text in half and rework
Talk to your client


Consider what is relevant for that particular
product
Present the information differently
(table/figure)

Translate the information

Make sure you understand the topic by
acquiring the necessary knowledge

Make sure you have enabled your audience
to understand the information
Make the format work for you

Segment the information into appropriate
chunks

Group similar information in a table, where the
data can be compared

Put the segments in a logical order

Move more detailed information to an appendix

Show the relationships among segments

Consider adding section summaries

Provide a home for all relevant information
Incorporate the ‘so what’

Providing the ‘so what’ is the most important technique to develop an effective dossier

The ‘so what’ for a piece of information can include:

Describing the consequences

Providing the context

Explaining the background
12

Making the connections